Konstantin Poukalov - Oct 29, 2021 Form 3 Insider Report for LianBio (LIAN)

Role
Director
Signature
/s/ Angela Chen, Attorney-in-Fact
Stock symbol
LIAN
Transactions as of
Oct 29, 2021
Transactions value $
$0
Form type
3
Date filed
10/29/2021, 06:36 PM
Previous filing
Jul 12, 2021
Next filing
Jun 21, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option shall vest and become exercisable on the first anniversary of the commencement date, December 17, 2021; the remainder shall vest and become exercisable in 3 equal annual installments such that the option shall be fully vested on December 17, 2024, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney